- Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024
- Melt Pharmaceuticals Closes $24 Million Series B Preferred Stock Financing
- Harrow Announces Fourth Quarter and Year-End 2023 Financial Results
- Harrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024
- Harrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical Products
- Harrow Announces New Appointments to its Board of Directors
More ▼
Key statistics
On Friday, Harrow Inc (HROWM:NMQ) closed at 25.78, -7.00% below its 52-week high of 27.72, set on Mar 01, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 25.90 |
---|---|
High | 25.94 |
Low | 25.78 |
Bid | 25.65 |
Offer | 27.00 |
Previous close | 25.78 |
Average volume | 2.95k |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Annual div (ADY) | 2.97 USD |
---|---|
Annual div yield (ADY) | 11.52% |
Div ex-date | Apr 12 2024 |
Div pay-date | Apr 30 2024 |
Data delayed at least 15 minutes, as of Apr 26 2024 19:30 BST.
More ▼